US Patent Issued to Amgen on May 19 for "Stabilized receptor polypeptides and uses thereof" (California, Massachusetts Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,608, issued on May 19, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Stabilized receptor polypeptides and uses thereof" was invented ... Read More

US Patent Issued to Ablynx, Sanofi on May 19 for "Techniques for predicting, detecting and reducing a specific protein interference in assays involving immunoglobulin single variable domains" (Belgian, German Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,609, issued on May 19, was assigned to Ablynx NV (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris). "Techniques for predicting, detecting and r... Read More

US Patent Issued to Mapp Biopharmaceutical on May 19 for "Anti-respiratory syncytial virus antibodies, methods of their generation and use" (New Hampshire Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,611, issued on May 19, was assigned to Mapp Biopharmaceutical Inc. (San Diego). "Anti-respiratory syncytial virus antibodies, methods of the... Read More

US Patent Issued to Vybion on May 19 for "Single chain intrabodies that alter huntingtin mutant degradation" (California Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,612, issued on May 19, was assigned to Vybion Inc. (Monterey, Calif.). "Single chain intrabodies that alter huntingtin mutant degradation" w... Read More

US Patent Issued to Takeda Pharmaceutical on May 19 for "Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use" (Austrian Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,613, issued on May 19, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Method to produce a highly concentrated immunoglobuli... Read More

US Patent Issued to H. LUNDBECK on May 19 for "Treatment of headache using anti-CGRP antibodies hereof" (American, Irish, Danish Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,614, issued on May 19, was assigned to H. LUNDBECK A/S (Valby, Denmark). "Treatment of headache using anti-CGRP antibodies hereof" was inven... Read More

US Patent Issued to THE BRIGHAM AND WOMEN'S HOSPITAL, SANOFI on May 19 for "Neutralizing anti-amyloid beta antibodies for the treatment of Alzheimer's disease" (American, French Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,615, issued on May 19, was assigned to THE BRIGHAM AND WOMEN'S HOSPITAL INC. (Boston) and SANOFI (Paris). "Neutralizing anti-amyloid beta an... Read More

US Patent Issued to CSL Innovation on May 19 for "Complement C2 binding proteins and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,616, issued on May 19, was assigned to CSL Innovation Pty Ltd (Melbourne, Australia). "Complement C2 binding proteins and uses thereof" was ... Read More

US Patent Issued to Ablynx, Sanofi on May 19 for "Serum albumin binders" (Belgian, British Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,617, issued on May 19, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris). "Serum albumin binders" was invented by S... Read More

US Patent Issued to Georgia Tech Research, Board of Regents, The University of Texas System on May 19 for "Anti-myocilin OLF antibodies and methods of use thereof" (Georgia, Florida, Texas Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,618, issued on May 19, was assigned to Georgia Tech Research Corp. (Atlanta) and Board of Regents, The University of Texas System (Austin, Te... Read More

• ««
• «
• 2730
• 2731
• 2732
• 2733
• 2734
• 2735
• 2736
• 2737
• 2738
• 2739
• »
• »»